Inventor
PHIASIVONGSA PASIT
US34 patents
⚠️ This page may combine multiple inventors who share the name “PHIASIVONGSA PASIT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONYX THERAPEUTICS INC
9 patentsUS8367617B2Feb 5, 2013
Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
ONYX THERAPEUTICS INC34 citations91
US9051353B2Jun 9, 2015
Crystalline tripeptide epoxy ketone protease inhibitors
ONYX THERAPEUTICS INC7 citations84
US8921583B2Dec 30, 2014
Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
ONYX THERAPEUTICS INC7 citations82
US9315542B2Apr 19, 2016
Prodrugs of peptide epoxy ketone protease inhibitors
ONYX THERAPEUTICS INC4 citations71
US9309283B2Apr 12, 2016
Prodrugs of peptide epoxy ketone protease inhibitors
ONYX THERAPEUTICS INC2 citations61
US8921324B2Dec 30, 2014
Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
ONYX THERAPEUTICS INC2 citations61
US9403868B2Aug 2, 2016
Crystalline tripeptide epoxy ketone protease inhibitors
ONYX THERAPEUTICS INC0 citations52
US10682419B2Jun 16, 2020
Prodrugs of peptide epoxy ketone protease inhibitors
ONYX THERAPEUTICS INC0 citations51
US9878047B2Jan 30, 2018
Prodrugs of peptide epoxy ketone protease inhibitors
ONYX THERAPEUTICS INC0 citations51
PRINCIPIA BIOPHARMA INC
6 patentsUS11667641B2Jun 6, 2023
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile
PRINCIPIA BIOPHARMA INC0 citations61
US11708370B2Jul 25, 2023
Solid forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
PRINCIPIA BIOPHARMA INC0 citations60
US12281120B2Apr 22, 2025
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile
PRINCIPIA BIOPHARMA INC0 citations59
US12410176B2Sep 9, 2025
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
PRINCIPIA BIOPHARMA INC0 citations56
US11814390B2Nov 14, 2023
Crystalline forms of 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-D]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile
PRINCIPIA BIOPHARMA INC0 citations56
US11583533B2Feb 21, 2023
Topical pharmaceutical compositions comprising 2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4,4-dimethylpent-2-enenitrile
PRINCIPIA BIOPHARMA INC0 citations38
SUPERGEN INC
5 patentsUS7700567B2Apr 20, 2010
Oligonucleotide analogues incorporating 5-aza-cytosine therein
SUPERGEN INC26 citations92
US7250416B2Jul 31, 2007
Azacytosine analogs and derivatives
SUPERGEN INC25 citations92
US7939546B2May 10, 2011
Quinoline derivatives for modulating DNA methylation
SUPERGEN INC14 citations80
US7790746B2Sep 7, 2010
Quinoline derivatives for modulating DNA methylation
SUPERGEN INC10 citations80
US7820684B2Oct 26, 2010
Pharmaceutical formulations comprising salts of a protein kinase inhibitor and methods of using same
SUPERGEN INC0 citations50
PHIASIVONGSA PASIT
4 patentsUS8461123B2Jun 11, 2013
Oligonucleotide analogues incorporating 5-aza-cytosine therein
PHIASIVONGSA PASIT11 citations92
US8604215B2Dec 10, 2013
Crystalline tripeptide epoxy ketone protease inhibitors
PHIASIVONGSA PASIT28 citations91
US8822512B2Sep 2, 2014
Crystalline tripeptide epoxy ketone protease inhibitors
PHIASIVONGSA PASIT6 citations83
US8697646B2Apr 15, 2014
Crystalline peptide epoxyketone immunoproteasome inhibitor
PHIASIVONGSA PASIT6 citations72
ASTEX PHARMACEUTICALS INC
4 patentsUS10456415B2Oct 29, 2019
Oligonucleotide analogues incorporating 5-aza-cytosine therein
ASTEX PHARMACEUTICALS INC3 citations83
US9480698B2Nov 1, 2016
Oligonucleotide analogues incorporating 5-aza-cytosine therein
ASTEX PHARMACEUTICALS INC8 citations83
US9358248B2Jun 7, 2016
Oligonucleotide analogues incorporating 5-aza-cytosine therein
ASTEX PHARMACEUTICALS INC8 citations83
US10933079B2Mar 2, 2021
Oligonucleotide analogues incorporating 5-aza-cytosine therein
ASTEX PHARMACEUTICALS INC0 citations62